NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

9791	Companies
196165	Keywords
127187	Articles
104305	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 05/28/2024 at 22:15, 1 year 8 months ago

NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference Call
Nanobiotix to present new data from Phase 1 immunotherapy program at 2024 ASCO meeting followed by investor conference call. Details for the call provided

Investor Conference Call Immunotherapy ASCO 2024 NANOBIOTIX Phase 1
BRIEF

published on 05/23/2024 at 22:20, 1 year 8 months ago

NANOBIOTIX to Present at the Jefferies Global Healthcare Conference

Biotechnology Cancer Treatment Webcast NANOBIOTIX Jefferies Global Healthcare Conference
BRIEF

published on 05/23/2024 at 22:20, 1 year 8 months ago

NANOBIOTIX fera une présentation à la conférence Jefferies Global Healthcare

Biotechnologie Webdiffusion Traitement Du Cancer NANOBIOTIX Conférence Mondiale Jefferies Sur Les Soins De Santé
PRESS RELEASE

published on 05/23/2024 at 22:15, 1 year 8 months ago

NANOBIOTIX to Present at the Jefferies Global Healthcare Conference
Nanobiotix to present at the Jefferies Global Healthcare Conference on June 5, 2024, with Bart Van Rhijn, CFO, participating in a fireside chat. Company pioneering physics-based approaches for cancer treatment

Cancer Treatment Biotechnology Company NANOBIOTIX Jefferies Global Healthcare Conference Physics-based Approaches
PRESS RELEASE

published on 05/23/2024 at 22:15, 1 year 8 months ago

NANOBIOTIX participera à la conférence Jefferies Global Healthcare
Nanobiotix participera à la conférence Jefferies Global Healthcare pour discuter de ses avancées en biotechnologie. Détails de l'événement et webcast disponibles

Biotechnologie Traitement Cancer NANOBIOTIX Conférence Jefferies
BRIEF

published on 05/21/2024 at 22:20, 1 year 8 months ago

Nanobiotix Announces Advancement in NBTXR3 Development and Strategic Collaboration

Biotechnology Cancer Therapy NANOBIOTIX NBTXR3 Janssen Collaboration
BRIEF

published on 05/21/2024 at 22:20, 1 year 8 months ago

Nanobiotix annonce des progrès dans le développement de NBTXR3 et une collaboration stratégique

Biotechnologie Thérapie Contre Le Cancer NANOBIOTIX NBTXR3 Collaboration Janssen
PRESS RELEASE

published on 05/21/2024 at 22:15, 1 year 8 months ago

Nanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipeline and Pathway to Long-Term Growth
Nanobiotix announces progress in global NBTXR3 development collaboration, highlighting robust pipeline and pathway to long-term growth in cancer treatment. Updates include US FDA approvals and strategic study modifications

Cancer Treatment NANOBIOTIX NBTXR3 Global Development FDA Approvals
PRESS RELEASE

published on 05/21/2024 at 22:15, 1 year 8 months ago

Nanobiotix annonce des avancees de la collaboration globale de developpement autour de NBTXR3 refletant son pipeline robuste et son approche de croissance sur le long terme
Nanobiotix annonce des avancées de la collaboration globale de développement autour de NBTXR3 reflétant son pipeline robuste et son approche de croissance sur le long terme

Croissance À Long Terme NANOBIOTIX NBTXR3 Collaboration Globale Pipeline Robuste
BRIEF

published on 05/14/2024 at 22:20, 1 year 8 months ago

NANOBIOTIX Lance une Étude de Phase 2 sur le Traitement du Cancer du Poumon avec FDA Approval

FDA Étude De Phase 2 NANOBIOTIX Cancer Du Poumon NBTXR3

Accesswire

Published on 02/03/2026 at 12:30, 35 minutes ago

Critical Elements Announces the Beginning of a 10,000-Meter Drill Program at Rose West
Published on 02/03/2026 at 12:30, 35 minutes ago

Critical Elements annonce le lancement d'un programme de forage de 10 000 mètres à Rose Ouest
Published on 02/03/2026 at 12:30, 35 minutes ago

Wolfden Announces Positive Preliminary Drill Results at its Rockland Gold Project in Nevada
Published on 02/03/2026 at 11:30, 1 hour 35 minutes ago

Caldwell Strengthens Life Sciences and Healthcare Practice with Addition of Dr. Christoph Themel as Partner
Published on 02/03/2026 at 09:01, 4 hours 4 minutes ago

Star Copper Completes Copperline Field Program with Drill Permit Submitted for 2026

View all ACCESSWIRE

EQS Group

Published on 02/03/2026 at 12:55, 10 minutes ago

ISX Financial EU PLC Appoints Andreas Artemiou as Chief Risk Officer
Published on 02/03/2026 at 12:45, 20 minutes ago

OneDosh Raises $3M Pre-Seed to Build Stablecoin-Powered Infrastructure for Cross-Border Payments
Published on 02/03/2026 at 12:15, 50 minutes ago

Global Leading RWA Network Plume Lowers the Barrier for Korean Institutional Investment Through the KRW1 Stablecoin
Published on 02/03/2026 at 12:08, 57 minutes ago

Original-Research: Almonty Industries Inc. (von Sphene Capital GmbH): Buy
Published on 02/03/2026 at 12:05, 1 hour ago

Cango Inc. Announces January 2026 Bitcoin Production and Mining Operations Update

Les Echos

Published on 02/03/2026 at 08:30, 4 hours 35 minutes ago

cegedim.cloud lance la nouvelle version d’Enercare, son module de calcul et de pilotage de l’empreinte carbone
Published on 02/03/2026 at 08:00, 5 hours 5 minutes ago

EURAZEO & PANTHEON ESTABLISH A NEARLY €500 MILLION PRIVATE DEBT CONTINUATION VEHICLE
Published on 02/03/2026 at 08:00, 5 hours 5 minutes ago

EURAZEO ET PANTHEON METTENT EN PLACE UN VÉHICULE DE CONTINUATION DE DETTE PRIVÉE DE PRÈS DE €500 MILLIONS
Published on 02/03/2026 at 08:00, 5 hours 5 minutes ago

Neoen lance la construction de trois nouveaux parcs solaires en France pour une capacité totale de 230 MWc
Published on 02/03/2026 at 08:00, 5 hours 5 minutes ago

Neoen launches three new solar farms in France with a total capacity of 230 MWp

View all LES ECHOS COMFI WIRE